Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 28 results for "Novartis Company"

Novartis India's board meeting on February 03, 2017

Novartis India Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on February 03, 2017, to consider unaudited financial results of the Company for third quarter and nine months ended December 31, 2016. Money Control, 2 months ago

142 images for Novartis Company

Lets Recycle, 1 month ago
Business Insider, 1 month ago
Reuters UK, 1 month ago
Sify, 1 month ago
Dotemirates.com, 2 months ago
Yahoo! Finance UK and Ireland, 1 month ago
Yahoo! UK and Ireland, 1 month ago
4 Traders, 1 month ago
Yahoo! News, 1 month ago
Reuters UK, 1 month ago
Money Control

Drugmakers in Davos shift focus to chronic diseases of poor

Twenty-two companies, including Pfizer, Merck, Novartis, Roche, Sanofi and GlaxoSmithKline, will contribute funds and expertise to the project, which is backed by the World Bank.
 Money Control2 months ago
Reuters

FDA approves Novartis drug as first-line treatment for breast cancer

(Reuters) - Novartis AG said on Monday that the U.S. Food and Drug Administration had approved the company's experimental drug, kisqali, as a first-line treatment for a type of breast cancer in postmenopausal women, in combination with another breast cancer ...
 Reuters1 week ago Novartis says Votubia receives EU approval for new indication  Reuters1 month ago

Lupin gets USFDA nod for generic inhalation product

Drug major Lupin has received approval from the US health regulator to market a generic version of Novartis' inhalation product Tobi, which is used to treat cystic fibrosis, in the American market. The company has received final approval from the US Food and ...
 Business Standard3 days ago
Rediff.com

Nestle India dons a new avatar

The company now plans to bet on health sciences, skin care and specialised products, says Arnab Dutta. After dominating the shelves of Indian retail and medical stores for over 104 years with its packaged foods and infant formulations, Swiss FMCG major Nestle has decided to change its game plan. The firm, which operates in 189 countries and owns over 2,000 brands, is working on a road map to shed the ‘food and nutrition company’ tag and emerge as a diversified entity by doubling the ...
 Rediff.com1 week ago
Sify

Trump to meet Novartis CEO, other pharma bosses on Tuesday

By John Miller (Reuters) - U.S. President Donald Trump, who has accused drugmakers of "getting away with murder" on prices, will meet executives from the pharmaceutical industry at the White House on Tuesday. Switzerland's Novartis said its chief executive ...
 Sify1 month ago Indian pharma's Trump fears  Rediff.com1 month ago Trump pushes drugmakers for lower prices, more U.S. production  Sify1 month ago
Sify

European blue chip stocks offer great income opportunities - Barron's

By Jarrett Renshaw NEW YORK (Reuters) - European blue-chip stocks Nestle, Royal Dutch Shell, Novartis and Unilever are expected to be among the best income-producing stocks of 2017, Barron's said in a report. Many European companies offering dividends ...
 Sify2 months ago
Sify

"It's like kumbaya:" Trump's genial private meetings with CEOs jar with public attacks

WASHINGTON - When the bosses of some of the world's largest pharmaceutical companies headed to Washington in January to meet U.S. President Donald Trump, it had all the makings of a potentially hostile meeting. Just weeks before, Trump had sent drug stock ...
 Sify2 weeks ago Insight - "It's like kumbaya:" Trump's genial private meetings with CEOs jar with public attacks  Sify2 weeks ago Insight - 'It's like kumbaya': Trump's genial private meetings with CEOs jar with public attacks  Sify2 weeks ago Insight: "It's like kumbaya:" Trump's genial private meetings with CEOs jar with public attacks  Sify2 weeks ago
Reuters

South Korea fines Novartis over kickbacks, suspends sales of some drugs

South Korea said it has fined Swiss drugmaker Novartis ( NOVN.S ) 200 million won ($174,937) and temporarily banned sales of some of its drugs for paying kickbacks to doctors in exchange for recommending the company's drugs. A spokeswoman for the Ministry of ...
 Reuters3 weeks ago
Reuters

Novartis says court battle will delay its Enbrel copy until 2018 at least

The Novartis copy of Amgen's blockbuster psoriasis drug Enbrel will not go on sale before 2018 at the earliest because of the U.S. company's patent protection challenge, the Swiss drugmaker's head of generics told Reuters. Though the U.S. Food and Drug ...
 Reuters1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less